Sekikawa, A., Fukui, H., Sada, R., Fukuhara, M., Marui, S., Tanke, G., et al. (2015) Gastric Atrophy and Xanthelasma Are Markers for Predicting the Development of Early Gastric Cancer. Journal of Gastroenterology, 51, 35-42.
https://doi.org/10.1007/s00535-015-1081-0

has been cited by the following article:

• TITLE: Research Progress on Gastric Xanthelasma

  AUTHORS: Jing Wang

  KEYWORDS: Gastric Xanthelasma, Helicobacter pylori, Diabetes Mellitus, Gastric Cancer

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.7, July 23, 2025

  ABSTRACT: Gastric xanthoma, also known as gastric xanthelasma or lipid island of the stomach, is a benign lipid deposition lesion occurring in the gastric mucosa. It is named for its yellowish-white macroscopic appearance and is histopathologically characterized by the accumulation of lipid-laden foam cells. The etiology and pathogenesis of this disease remain unclear, but it has been hypothesized to be associated with chronic gastritis, Helicobacter pylori (H. pylori) infection, diabetes mellitus, and hyperlipidemia. Recent studies indicate a significantly increased risk of gastric cancer in patients with gastric xanthoma, though the precise association between the two remains unclear. Therefore, this review comprehensively examines gastric xanthoma.